A Peek into the Future – Repair and Replacement of the Mitral and Tricuspid Valves with the Edwards Portfolio: On-demand Programme
-
12m 39s
-
46m 38s
This on-demand version of the broadcast 'A Peek into the Future – Repair and Replacement of the Mitral and Tricuspid Valves with the Edwards Portfolio' comprises an internationally-respected faculty, as they review the PASCAL platform focusing on the recently CE mark approved PASCAL Ace implant system for the treatment of mitral and tricuspid regurgitation. Under the stewardship of programme Chair, Prof Nicolas van Mieghem, Erasmus Medical Center, Rotterdam, this programme examines the role of the PASCAL platform the the treatment of MR, the PASCAL Ace Implant System in the treatment of TR, valve replacement with EVOQUE, and includes a live procedure from Heidelberg University Hospital to best enhance practical learnings.
Pipeline products for tricuspid transcatheter replacement from Edwards Lifesciences will be shown and briefly discussed.
Learning objectives
- Outline the pathogenic nature and clinical risk of extended exposure to elevated LDL-C
- Describe the clinical challenges in achieving guideline-based LDL-C goals
- Compare and contrast LDL-C lowering therapies
Audience
- Interventional Cardiologists
- General Cardiologists
- Heart Failure Specialists
- Echocardiographers
- Nurses
More from this programme
Part 1
Introduction – A Peek into the Future Repair and Replacement of the Mitral & Tricuspid Valves With the Edwards Portfolio
Part 2
The PASCAL Platform – Successfully and Confidently Treat MR
Part 3
The PASCAL Ace Implant System – Therapy to Successfully Treat TR
Part 4
Looking into the Future – Valve Replacement with the EVOQUE
Part 5
Case – PASCAL Ace Implant System for the Treatment of TR
Faculty Biographies
Peter Lüdike
Senior Physician
Prof Peter Lüdike is Senior Physician of the Heart Failure and Intensive Care section in the Department of Cardiology and Vascular Medicine at the West German Heart and Vascular Center, University Hospital Essen. He achieved Venia legendi for internal medicine in 2018 and was appointed as Full Professor for heart failure in 2020. His research interests include intensive care medicine, emergency medicine, heart failure, mitral valve disease and the role of macrophage migration inhibitory factor in the development of ischaemic heart disease.